media – Page 473 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Enquiry for Nucala in COPD

Nucala (mepolizumab) was first approved as the first anti-IL5 treatment for adults and adolescents with severe asthma accompanied by eosinophilic phenotype in the United States during November 2015. Later it was approved to treat eosinophilic granulomatosis with polyangiitis (EGPA).
- Source: BioPharmaDive
- 774
- July 26, 2018
COPD GSK New Approvals
Curcumin in Turmeric can Treat Glaucoma

Glaucoma is an eye disorder causing irreversible blindness and affects around 60 million people throughout the world. This condition leads to the loss of retinal ganglion cells, located near the surface of the retina. The prime focus of glaucoma research is to put an end to the loss of these cells in the initial stages.
- Source: MedicalXpress
- 1,264
- July 26, 2018
glaucoma Researches tumeric
Europe Approves InPen; Makes Insulin Injections Easier

San Diego based Companion Medical got its InPen insulin management system certified with the European CE Mark of approval.
- Source: MedGaget
- 331
- July 26, 2018
diabetes insulin mHealth New Approvals
Synopsys Ranks Medical Records Higher than Credit Card Details

Olli Jarva, Synopsys’s Software Integrity Group managing consultant, opined that hackers find healthcare data of more value than credit card or social security details, referring to the recent ransomware attack on Singapore’s government health database.
- Source: The Verdict
- 753
- July 26, 2018
digital health EHR Researches
Invention of Cortisol Detecting Wearable to Measure Stress

The research team from Stanford University have invented a novel wearable that could measure the level of a patient’s cortisol from their sweat. Cortisol is a hormone linked to stress, which takes several days to test. This scientific discovery was recently published in Science Advances.
- Source: MobiHealthNews
- 681
- July 25, 2018
digital health Researches wearables
Novartis Neuroendocrine Tumor App Featured in iStore

In a recent launch, Novartis’ Galaxies of Hope neuroendocrine tumor app received an additional bump from Apple. The “Featured App” status in the first week itself helped in receiving positive reviews and downloads for the community-building app.
- Source: FiercePharma
- 794
- July 25, 2018
Company Insight mHealth Novartis
Bayer Announces the end of Essure Sales in the US

Bayer announced on last Friday that it would stop the sales of its Essure birth control system in the United States by the end of this year due to a steady decline in its sales making the product no longer justifiable. Bayer insisted that its decision to discontinue Essure sales is only for business reasons and not for any safety or efficacy concerns.
- Source: MDDI Online
- 644
- July 25, 2018
Company Insight contraceptive device FDA
Recently Discovered Kidney Cancer Driver could be Future Therapy Target

Scientists from the University of North Carolina Lineberger Comprehensive Cancer Center have discovered a probable remedial target for kidney cancers with the same genetic alteration. It is well-known fact to scientists that this change in the genetic patterns can result in a plethora of blood vessels, which form a channel for nutrients to reach the tumors.
- Source: ScienceDaily
- 435
- July 25, 2018
kidney Researches
New Simplified Formula Tested for Assessment of MRI in Crohn’s Disease

A Spanish research team who gained fame for introducing the MRI-based formula that grades the activity of luminal Crohn’s disease in 2011, recently developed and tested a fresh, easier adaptation of their MRI score that leads to a swifter assessment.
- Source: MDEdge
- 631
- July 25, 2018
Crohn’s disease medtech Researches
NHS to Utilize $540 Million New Funding to Boost Hospital IT

Matt Hancock, new Health and Social Care Secretary, announced that information technology would be among his prime subject of focus for the betterment of National Health Service.
- Source: HealthcareIT News
- 764
- July 25, 2018
digital health EHR New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.